Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
These findings warrant further investigation in prospective controlled studies to evaluate the therapeutic role of GLP-1 RAs in PsA management and its frequent comorbidities
While rare, studies suggest the risk may be higher in users of GLP-1 drugs
The peptide molecules are clumping together, which means they are no longer in their active form
Therapeutic Pipeline: Whats Next for GLP-1s and Beyond The field of obesity medicine is evolving rapidly, with once-monthly injectables like maridebart cafraglutide (MariTide) delivering promising results in late-stage trials
10.1016/j.isci.2024.109737 84 PontelL
Patients with Active Psychiatric Conditions Given BPC-157's documented effects on dopamine and serotonin systems, patients with bipolar disorder, schizophrenia, or active major depressive disorder on psychoactive medications represent an unstudied population where caution is warranted
